Off-label prescriptions: taking responsibility
نویسندگان
چکیده
منابع مشابه
Physicians' liability for off-label prescriptions.
It is estimated that between 40 and 60 percent of all prescriptions written in the United States are for off-label uses. Off-label uses are common, especially for treating cancer, AIDS, pediatric conditions and rare diseases. Because the practice is common, and in many cases necessary, physicians must consider how prescribing drugs for uses not recommended by the manufacturer—and not approved b...
متن کاملNo evidence or no alternative? Taking responsibility for off-label prescribing.
Recombinant activated factor VII (rFVIIa) is registered for patients with rare haematological disorders, but is used 'off-label' in many other situations, including intracranial haemorrhage, cardiac surgery, trauma, transplantation and prostatectomy. Lack of systematic evidence to support these off-label uses has not slowed the growth of off-label prescribing of rFVIIa. We use the case of rFVII...
متن کاملOff-label prescriptions in Italian hospices: a national survey.
Off-label prescription is part of routine care in palliative medicine, but no information is available about the situation in Italy. A cross-sectional observational survey was undertaken on all 66 Italian palliative care freestanding inpatient units to describe off-label prescriptions. Data were collected on 507 patients. Each prescribed drug was matched with Italian Marketing Authorization ind...
متن کاملOff-label prescriptions in intensive care unit: the Chinese experience
Background and purpose Off-label prescriptions for critically ill patients pose several ethical and legal dilemmas for intensive care unit (ICU) clinicians. Yet, few data are available on the prevalence of this practice in critical care environment in China. This nationwide survey was performed to evaluate the conditions of off-label prescriptions in ICU within China. Methods The survey was p...
متن کاملUtilisation and Off-Label Prescriptions of Respiratory Drugs in Children
Respiratory drugs are widely used in children to treat labeled and non-labeled indications but only some data are available quantifying comprehensively off-label usage. Thus, we aim to analyse drug utilisation and off-label prescribing of respiratory drugs focusing on age- and indication-related off-label use. Patients aged ≤18 years documented in the Bavarian Association of Statutory Health In...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Management Issues
سال: 2011
ISSN: 2283-3137,1973-4832
DOI: 10.7175/cmi.v5i2.504